Sickle Cell Disease is a genetic blood disorder heavily impacting India's tribal populations. The National Sickle Cell Anaemia Elimination Mission aims to screen 7 crore individuals and eradicate the disease by 2047 through aggressive genetic counseling, hydroxyurea therapy, and emerging CRISPR-Cas9 gene-editing solutions.
Click to View MoreUnion Government launched BIRSA 101, India's first indigenous CRISPR gene therapy targeting Sickle Cell Disease. Developed by CSIR-IGIB and SII, this affordable enFnCas9 technology primarily benefits tribal communities, accelerating the National Sickle Cell Elimination Mission 2047
Click to View More
© 2026 iasgyan. All right reserved
